Mechanistic stratification of antineuralgic agents.

Abstract

Current treatment options in neuropathic pain include antidepressants, antiepileptics, antiarrhythmics, and analgesics. However, stratification of treatments based on their original therapeutic class is inadequate, as drugs belonging to a particular class may have distinct antineuralgic modes of action. It is therefore useful to review the mechanisms of action of these drugs and determine which of these mechanisms is most likely responsible for the drugs' efficacy in the symptomatic treatment of neuropathic pain. Switching from the traditional therapeutic class stratification to one based on putative antineuralgic mechanisms of action will allow more rational selection of therapies, and aid evaluation of the additive or synergistic effects of drugs when used in combination.

• Authors: Ahmad Beydoun, Misha-Miroslav Backonja
• Journal: Journal of pain and symptom management (J Pain Symptom Manage) Vol. 25 Issue 5 Suppl Pg. S18-30 (May 2003) ISSN: 0885-3924 [Print] United States
• PMID: 12694989 (Publication Type: Journal Article, Review)

Chemical References

• Analgesics
• Anesthetics, Local
• Anti-Arrhythmia Agents
• Anticonvulsants
• Antidepressive Agents

Topics

• Analgesics (classification, therapeutic use)
• Anesthetics, Local (therapeutic use)
• Anti-Arrhythmia Agents (therapeutic use)
• Anticonvulsants (therapeutic use)
• Antidepressive Agents (therapeutic use)
• Brain (drug effects, physiopathology)
• Central Nervous System Diseases (complications, drug therapy, physiopathology)
• Humans
• Neuralgia (diagnosis, drug therapy, etiology, physiopathology)
• Pain (diagnosis, drug therapy, etiology, physiopathology)
• Peripheral Nerves (drug effects, physiopathology)
• Peripheral Nervous System Diseases (complications, drug therapy, physiopathology)
• Quality Control
• Spinal Cord (drug effects, physiopathology)